Description
RKN5755 is a selective activated fibroblasts inhibitor that acts by inhibiting the enhanced migration of fibroblasts cocultured with cancer cells by binding to beta-arrestin1 and interfering with beta-arrestin1-mediated cofilin signaling pathways